Nearly 5 million people worldwide have lupus. If left unmanaged, this chronic autoimmune condition can progress and lead to severe disease flares.

This #WorldLupusDay , find tips for talking with your doctor: bit.ly/3PZpAFp

#MakeLupusVisible #LupusAwareness

Everyday we’re working to push the frontiers of respiratory medicine. We’re committed to deliver the next generation standard of care in asthma treat the symptoms and the underlying cause of inflammation, exacerbations and cumulative lung damage.

This World Ovarian Cancer Day, we are raising awareness for the tens of thousands of women diagnosed with #ovariancancer each year. Hear from Carmen about navigating her diagnosis. #WOCD2024 #NoWomanLeftBehind

Our CEO Emma Walmsley has been at #MIGlobal sharing how we’re using science and tech to prevent and change the course of disease – and why we’re partnering with @MilkenInsitute to help health systems invest in prevention and earlier intervention: gsk.to/4bnNeDA

For more than 50 years, inhalers have helped millions of people manage their asthma, but they also contribute to greenhouse gas emissions.

Discover why low carbon inhalers could help patients while reducing our environmental impact. #WorldAsthmaDay

gsk.to/3wb2Mf8

On #WorldAsthmaDay we say thank you to the patients in our clinical trials or share their experiences, the experts and patient organisations who partner with us and GSK employees who are working tirelessly to deliver the next generation of #asthma care.

From vaccines to help protect all stages of life to working to change the course of diseases like asthma and hepatitis B, we’re innovating to get ahead of disease, together. Read more 👉 gsk.to/3Wt2dI2

We’re pleased to be the founding partner of Project Prevent, a new initiative from Milken Institute bringing together cross-sector experts to accelerate investment in, and access and uptake of, preventative healthcare. #MIGlobal
Find out more:
gsk.to/4bnNeDA

Looking forward to our CEO Emma being part of the conversation on shaping our shared future at #MIGlobal this weekend.

Get to know our #TargetTheFuture grant recipient: Cancer Support Community! Learn more about how their programme is connecting #multiplemyeloma patients and caregivers with vital resources: gsk.to/4aY7Z9i #AheadTogether

Do you have #asthma or nasal polyps?
You are the experts on these conditions and your voice is important. We’re delighted to have partnered with Global Allergy & Airways Patient Platform on this survey to help improve understanding of these conditions.
Complete the survey here by 12 May…

News for #Investors and #Media

We’ve announced our Q1 2024 results. Review our key highlights. For more insights, visit us at gsk.to/44kqCSf. $GSK

News for #Investors and #Media

Explore our Q1 2024 figures at a glance. gsk.to/4aUgYZ5. $GSK

#Investors : Join GSK’s CEO Emma Walmsley and other members of our leadership team for our Q1 2024 live results webcast at 12:00 BST, 07:00 EDT. $GSK

News for #Investors and #Media

Hear our CEO Emma Walmsley talk about our strong Q1 performance and learn more about our upgraded outlooks for the year.

For more, see gsk.to/3wgznQu
$GSK #NEWS #Q1Results

#Investors and #MediaPlease read our cautionary statement regarding forward-looking statements and the definitions and reconciliations for non-IFRS measures for our Q1 2024 results. CER% represents constant exchange rates. £% or AER% represents actual exchange rates. $GSK For…

We’re announcing our Q1 2024 results tomorrow at 0700 BST, 0200 EDT. $GSK

As people’s immune systems weaken with age, the burden of vaccine-preventable diseases rises. That’s what motivates us to work towards making adult immunisation the standard of care across the globe. #WIW2024 gsk.me/3JI28Jc